nafamostat has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bae, KH; Chi, SW; Cho, S; Kang, S; Kim, JH; Kim, S; Lee, PY; Park, BC; Park, SG | 1 |
2 other study(ies) available for nafamostat and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Histone H4 is cleaved by granzyme A during staurosporine-induced cell death in B-lymphoid Raji cells.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Benzamidines; Blotting, Western; Caspase Inhibitors; Cell Line, Tumor; Flow Cytometry; Granzymes; Guanidines; HEK293 Cells; HeLa Cells; Histones; Humans; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Staurosporine | 2016 |